Mirae Asset Global ETFs Holdings
TLSI icon

Mirae Asset Global ETFs Holdings’s TriSalus Life Sciences TLSI Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Buy
22,073
+7,638
+53% +$30.4K ﹤0.01% 2824
2026
Q1 		$57.7K Buy
14,435
+300
+2% +$1.47K ﹤0.01% 2871
2025
Q4 		$98.7K Buy
14,135
+5,461
+63% +$30.6K ﹤0.01% 2685
2025
Q3 		$40.3K Sell
8,674
-31
-0.4% -$145 ﹤0.01% 2982
2025
Q2 		$47.4K Buy
+8,705
New +$46.7K ﹤0.01% 2892

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TLSI Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its TriSalus Life Sciences (TLSI) stake by 53% in Q2 2026, buying an estimated $30.4K and bringing the position to 22,073 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

Mirae Asset Global ETFs Holdings first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 22,073 shares of TriSalus Life Sciences worth $100K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 7,638 TriSalus Life Sciences shares in Q2 2026, an estimated $30.4K.
  • TriSalus Life Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2824 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.